|
AU2020104403A4
|
|
Compound and application thereof in synthesis of pdl1 antagonist drug molecules
|
|
WO2021018172A1
|
|
Adenosine receptor antagonist
|
|
WO2021018173A1
|
|
Adenosine receptor antagonist
|
|
TW202045487A
|
|
Pd-l1 antagonist compounds
|
|
WO2020042995A1
|
|
Highly active sting protein agonist compound
|
|
CN111386275A
|
|
High activity STING protein agonists
|
|
CN111518016A
|
|
CSF1R inhibitor intermediate and preparation method thereof
|
|
WO2019158070A1
|
|
A2a and/or a2b receptor antagonist
|
|
CN111518076A
|
|
Preparation method of indoleamine-2, 3-dioxygenase (IDO) inhibitor
|
|
CN111741946A
|
|
Indoleamine 2, 3-dioxygenase inhibitors and their use in medicine
|
|
WO2019024150A1
|
|
Ternary transcription factor and application thereof in mammalian protein expression system
|
|
WO2018098854A1
|
|
Synthesis and screening method for dna-coding dynamic molecular library
|
|
WO2017113444A1
|
|
Her-2 polypeptide for tumor, composition, preparation method and application
|
|
WO2017113445A1
|
|
Erythropoietin peptide, derivatives and polymers, preparation method and application
|
|
WO2017101144A1
|
|
Adipose tissue targeting polypeptide, preparation method therefor and application thereof
|
|
WO2017092083A1
|
|
Dpp-4 inhibitor compound, polymer and preparation method and use of same
|
